Skip to main content

Find Clinical Trials

Home
Conditions
Immune Thrombocytopenia

Clinical trial condition

Immune Thrombocytopenia

Explore clinical trials studying Immune Thrombocytopenia. Study availability and eligibility vary by location and protocol.

96 public trials 33 recruiting studies

Refine in advanced search Browse all conditions

Immune Thrombocytopenia trial results

Completed

Eltrombopag and the Bcl-extra-large (xL) Pathway in Idiopathic Thrombocytopenic Purpura (ITP)

NCT00902018

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Weill Cornell Medical College New York, United States

View Trial Details

Completed

A Multi-center Study of Low-dose Decitabine for the Treatment of Immune Thrombocytopenia

NCT01568333

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Shandong University Qilu hospital Jinan, Shandong, China

View Trial Details

Completed

Reposition of Second Line Treatment in Chronic Immune Thrombocytopenia

NCT03229746

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Assiut university hospital Asyut, Egypt

View Trial Details

Completed

Efficacy and Safety of Oral E5501 Plus Standard of Care for the Treatment of Thrombocytopenia in Adults With Chronic Immune Thrombocytopenia (Amendment 02)

NCT01438840

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +17 more
Locations: Adelaide, Australia

Bedford Park, Australia

Antwerp, Belgium

Plovdiv, Bulgaria

View all 25 locations

View Trial Details

Completed

Polymorphism and Auto-reactive B and T Cells Subsets in Adult's Immune Thrombocytopenia (ITP)

NCT02287649

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Henri Mondor Hospital Créteil, France

View Trial Details

Completed

The Study of Different Dose Rituximab in the Treatment of ITP

NCT03258866

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Qilu hospital, Shandong University Jinan, Shandong, China

View Trial Details

Completed

Genome-Wide Gene Expression Profiling of Patients With ITP Receiving Thrombopoietin Mimetics

NCT01727999

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Stanford University Stanford, California, United States

Weill Medical College, Cornell University New York, United States

View Trial Details

Completed

Safety and Efficacy Study of Romiplostim to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients

NCT01444417

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +20 more
Locations: Research Site Orange, California, United States

Research Site San Diego, California, United States

Research Site Washington D.C., District of Columbia, United States

Research Site Atlanta, Georgia, United States

View all 33 locations

View Trial Details

Completed

A Retrospective Chart Review of Thirty Three Children Who Have Received Clinical Treatment With Either Romiplostim or Eltrombopag From 2009-2013

NCT01974232

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +17 more
Locations: Weill Cornell Medical College New York, United States

View Trial Details

Completed

An Open Phase 3 Study of IV-Globulin SN Inj.10% to Treat Immune Thrombocytopenia

NCT02063789

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Chungnam National University Hospital Daejeon, South Korea

Daegu Catholic University Medical Center Deagu, South Korea

Chonnam National University Hwasun Hospital Hwasun, South Korea

Gachon University Gil Medical Center Incheon, South Korea

View all 14 locations

View Trial Details